136 related articles for article (PubMed ID: 2676122)
1. Alterations in myocardial fatty acid metabolism contribute to ischemic injury in the diabetic.
Lopaschuk GD
Can J Cardiol; 1989 Sep; 5(6):315-20. PubMed ID: 2676122
[TBL] [Abstract][Full Text] [Related]
2. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
Rosano GM; Vitale C; Fragasso G
Am J Cardiol; 2006 Sep; 98(5A):14J-18J. PubMed ID: 16931201
[TBL] [Abstract][Full Text] [Related]
3. Alterations in myocardial metabolism in the diabetic myocardium.
Lazar HL
Semin Thorac Cardiovasc Surg; 2006; 18(4):289-92. PubMed ID: 17395024
[TBL] [Abstract][Full Text] [Related]
4. [The heart in diabetics].
Bĕlobrádková J; Filipenský B
Vnitr Lek; 2003 Dec; 49(12):921-6. PubMed ID: 15040156
[TBL] [Abstract][Full Text] [Related]
5. Targets for modulation of fatty acid oxidation in the heart.
Lopaschuk GD
Curr Opin Investig Drugs; 2004 Mar; 5(3):290-4. PubMed ID: 15083595
[TBL] [Abstract][Full Text] [Related]
6. [Metabolic considerations in the treatment of coronary disease in diabetic patients].
Piot C
Diabetes Metab; 2001 Nov; 27(5 Pt 2):S25-9. PubMed ID: 11910982
[TBL] [Abstract][Full Text] [Related]
7. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
8. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts.
Onay-Besikci A; Guner S; Arioglu E; Ozakca I; Ozcelikay AT; Altan VM
Can J Physiol Pharmacol; 2007 May; 85(5):527-35. PubMed ID: 17632588
[TBL] [Abstract][Full Text] [Related]
9. Metabolic therapy for the treatment of ischemic heart disease: reality and expectations.
Wang W; Lopaschuk GD
Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1123-34. PubMed ID: 18035928
[TBL] [Abstract][Full Text] [Related]
10. [Metabolism of long chain fatty acids in the normal and pathologic heart: effects of ischemia].
Feuvray D; Leblond Y
Diabete Metab; 1984 Dec; 10(5):316-23. PubMed ID: 6397367
[TBL] [Abstract][Full Text] [Related]
11. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
[TBL] [Abstract][Full Text] [Related]
12. Metabolism in non-ischemic myocardium during coronary artery occlusion and reperfusion.
Buxton DB; Mody FV; Krivokapich J; Schelbert HR
J Mol Cell Cardiol; 1993 Jun; 25(6):667-81. PubMed ID: 8411193
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
Niu YG; Evans RD
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
[TBL] [Abstract][Full Text] [Related]
14. [Intermediate myocardial metabolism. Changes in ischemia, diabetes and hyperthyroidism].
Feuvray D; Khandoudi N; Lagadic-Gossmann D; Besse S
Arch Mal Coeur Vaiss; 1988 Oct; 81 Spec No():29-33. PubMed ID: 3145722
[TBL] [Abstract][Full Text] [Related]
15. Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated?
Lopaschuk GD
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S8-11. PubMed ID: 11286307
[TBL] [Abstract][Full Text] [Related]
16. [Change of glucose transporter 4 and its influence on glucose and fatty-acid metabolism in type 2 diabetic myocardium].
Wen ZY; Wu Y; Li Y; Chen XL; Wang T; Ouyang JP; Li GS
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1460-3. PubMed ID: 16061022
[TBL] [Abstract][Full Text] [Related]
17. Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study.
Welch MJ; Lewis JS; Kim J; Sharp TL; Dence CS; Gropler RJ; Herrero P
J Nucl Med; 2006 Apr; 47(4):689-97. PubMed ID: 16595504
[TBL] [Abstract][Full Text] [Related]
18. Diabetes-related metabolic perturbations in cardiac myocyte.
Feuvray D; Darmellah A
Diabetes Metab; 2008 Feb; 34 Suppl 1():S3-9. PubMed ID: 18358420
[TBL] [Abstract][Full Text] [Related]
19. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
Aasum E; Cooper M; Severson DL; Larsen TS
Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
[TBL] [Abstract][Full Text] [Related]
20. Myocardial blood flow and metabolism in humans.
Schelbert HR
Z Kardiol; 1984; 73 Suppl 2():113-8. PubMed ID: 6335622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
